● Overall, the company has poor fundamentals for a medium to long-term investment strategy.
● The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
● For the past twelve months, EPS forecast has been revised upwards.
● Over the past four months, analysts' average price target has been revised upwards significantly.
● Analyst opinion has improved significantly over the past four months.
● Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
● Low profitability weakens the company.
● The company is in debt and has limited leeway for investment
● The company appears highly valued given the size of its balance sheet.
● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.